ContraFect Corporation to Announce First Quarter 2016 Results on May 10, 2016
03 mai 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - May 03, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a clinical-stage biotechnology company focused on the discovery and...
ContraFect to Present CF-301 Phase 1 Trial Data at the 26th ECCMID Conference
29 mars 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 29, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a biotechnology company focused on the discovery and...
ContraFect Announces Fourth Quarter and Full Year 2015 Results
15 mars 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 15, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
Avid Bioservices Announces Addition of Novel Bacteriophage Production System at Upcoming BIO Conference as Part of a Collaboration With Phage Pharmaceuticals
11 juin 2012 16h30 HE
|
Avid Bioservices
TUSTIN, CA--(Marketwire - Jun 11, 2012) - Avid Bioservices, a subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that it will collaborate with San Diego-based Phage...